H. Hwang

Yu-Jin Jung, Yu-Na Lee, Young‐Tae Lee, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Antiviral activity of ginseng extract against respiratory syncytial virus infection

Yu-Na Lee, Min-chul Kim, Sang-Moo Kang, 2014, International journal of molecular medicine.

Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.

F. Quan, Bao-Zhong Wang, Young‐Tae Lee, 2018, Virology.

Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells

Young‐Tae Lee, Min-chul Kim, Ki-hye Kim, 2015, Journal of Virology.

AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.

Yu-Na Lee, Young‐Tae Lee, Min-chul Kim, 2014, Vaccine.

Immunomodulatory Activity of Red Ginseng against Influenza A Virus Infection

Yu-Na Lee, Min-chul Kim, Sang-Moo Kang, 2014, Nutrients.

COVID-19 Vaccine Acceptance in the US and UK in the Early Phase of the Pandemic: AI-Generated Vaccines Hesitancy for Minors, and the Role of Governments

Chiyoung Cha, M. Cha, H. Hwang, 2020, The Korean Data Analysis Society.

Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

F. Quan, Young‐Tae Lee, Min-chul Kim, 2014, Vaccine.

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Jian-Dong Li, Yu-Jin Jung, Young‐Tae Lee, 2014, Antiviral research.

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform

F. Quan, Young‐Tae Lee, Min-chul Kim, 2019, Immune network.

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization

J. Rhee, Shee-Eun Lee, H. Hwang, 2018, Human vaccines & immunotherapeutics.

Tumor Microenvironment-Regulating Immunosenescence-Independent Nanostimulant Synergizing with Near-Infrared Light Irradiation for Antitumor Immunity.

Ansuja Pulickal Mathew, J. Rhee, Saji Uthaman, 2021, ACS applied materials & interfaces.

Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Virology.

Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression

J. Rhee, Shee-Eun Lee, Y. Jeong, 2020, Cells.

Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Carlo Montemagno, Min-Chul Kim, Hyo-Jick Choi, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

F. Quan, Young‐Tae Lee, Min-chul Kim, 2015, Nanomedicine : nanotechnology, biology, and medicine.

The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

Yu-Jin Jung, B. Seong, Young‐Tae Lee, 2019, Antiviral research.

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.

Yu-Jin Jung, Yu-Jin Kim, Young‐Tae Lee, 2016, Virology.

EFFICACY AND SAFETY OF VIRUS LIKE PARTICLE VACCINES AGAINST RESPIRATORY SYNCYTIAL VIRUS IN MOUSE AND COTTON RAT MODELS

H. Hwang, 2016 .

Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2020, Immune network.

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.

B. Graham, Young‐Tae Lee, Ki-hye Kim, 2019, Virology.

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.

Yu-Jin Kim, Young‐Tae Lee, Min-chul Kim, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.

Young‐Tae Lee, Min-chul Kim, Sang-Moo Kang, 2015, Antiviral research.

Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2021, Vaccines.

A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases

S. Kim, J. Rhee, Shee-Eun Lee, 2018, Mucosal Immunology.

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles

Young‐Tae Lee, Ki-hye Kim, Sang-Moo Kang, 2017, Human vaccines & immunotherapeutics.

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines

Sang-Moo Kang, H. Hwang, Chau Thuy Tien Le, 2023, Scientific reports.